AI assistant
BIO-TECHNE Corp — Director's Dealing 2025
Aug 19, 2025
30718_dirs_2025-08-19_cd52ee54-d5f8-4aef-9c16-969eeae56f5d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-08-15
Reporting Person: Herr Amy E. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-15 | Common Stock | M | 279 | — | Acquired | 2255 | Indirect |
| 2025-08-15 | Common Stock | F | 101 | $53.60 | Disposed | 2154 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-15 | Restricted Stock Units | $ | M | 119 | Disposed | Common Stock (119) | Indirect | |
| 2025-08-15 | Restricted Stock Units | $ | M | 160 | Disposed | Common Stock (160) | Indirect | |
| 2025-08-15 | Restricted Stock Units | $ | A | 932 | Acquired | Common Stock (932) | Indirect | |
| 2025-08-15 | Stock Option (Right to Buy) | $53.60 | A | 2735 | Acquired | 2035-08-15 | Common Stock (2735) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1040 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (2415) | 2415 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (6636) | 6636 | Indirect |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (4472) | 4472 | Indirect |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (2076) | 2076 | Indirect |
| Stock Option (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (2104) | 2104 | Indirect |
| Stock Option (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (1084) | 1084 | Indirect |
| Stock Option (Right to Buy) | $74.91 | 2034-08-15 | Common Stock (1468) | 1468 | Indirect |
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (344) | 344 | Indirect |
| Restricted Stock Units | $ | Common Stock (115) | 115 | Indirect |
Footnotes
F1: This option vests on the earlier of the one-year anniversary of the grant date (2/3/2025) or the date of Bio-Techne's 2025 annual meeting of shareholders.
F2: Fully vested.
F3: Options to purchase 520 shares vest on each of 8/6/2022, 8/6/2023 and 8/6/2025; and options to purchase 516 shares vest on 8/6/2024.
F4: Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.
F5: Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
F6: Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F7: Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
F8: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F9: 119 restricted stock units vest on 8/15/2025 and 118 restricted stock units vest on 8/15/2026.
F10: 160 restricted stock units vest on each of 8/15/2025, 8/15/2026 and 8/15/2027.
F11: 38 restricted stock units vest on each of 2/3/2026 and 2/3/2027, and 39 restricted stock units vest on 2/3/2028.
F12: 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
F13: Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.